DTK of Medicines from Bio-piracy: Its conscientiousness by TKDL of India

  • Posted on: 31 March 2016
  • By: admin

Magazine Home


April 2016 ARTICLE LIST >>

PharmaTutor (April- 2016)

 

Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 4, Issue 4)

 

Received On: 16/11/2015; Accepted On: 03/12/2015; Published On: 01/04/2016

 

AUTHORS:
NG Dhawan*1, Manisha Mavai2, Priyanka Bishnoi3, Raaz K Maheshwari3
1Amity Institute of Environmental Sciences, Amity University, Noida, UP, India
2Department of Botany Physiology, AIIMS, Jodhpur, Rajasthan, India
3Department of Botany & Biotechnology, University of Rajasthan, Rajasthan, India
4Department of Chemistry, SBRM Govt PG College, Nagaur, India
*rkmgreenchem.jaipur@gmail.com

 

ABSTRACT: The genetic resources and indigenous communities traditional knowledge of developing countries is being exploited by the Developed countries in the name of patents for inventions that are derived from genetic resources. The exploitation of genetic resources and indigenous communities traditional knowledge by the developed countries in the name of patents on the inventions derived from those genetic resources is actually bio-piracy. Protection of the TK of the local and indigenous communities appears to be one of the most debatable and complex issues. This paper brings out the role of domestic IPR constitution that looks to protect traditional system of medicine and associated TK in Indian sub-continent. Further, it attempts to validate the necessity of introduction of a national TKDL, which can be utilized as an evidence of the 'prior art' by the examiners of patent offices, nationally as well as internationally. Thus, it aims to address the concerns relating to the creation of TKDL in India.

 

 

How to cite this article: Dhawan NG, Mavai M, Bishnoi P, Maheshwari RK; DTK of Medicines from Bio-piracy: Its conscientiousness by TKDL of India; PharmaTutor; 2016; 4(4); 13-17

 

[ABSTRACT WITH CITATION]   [VIEW AS HTML]